Using thousands of AI agents to uncover new leads in biological data
What happened
OpenAI, PerturbAI and Scripps Research used thousands of AI agents powered by GPT‑Rosalind to analyze a whole‑brain CRISPR atlas of mouse brain cells, linking gene disruptions to cellular effects and scientific literature in about 32 minutes. Each agent examined a single gene perturbation, interpreted the data, searched papers and suggested explanations, creating a combined reasoning atlas that maps genes, outcomes, publications and possible mechanisms. The AI‑driven analysis reproduced human findings that would have taken months or a year, while also uncovering new leads such as differing impacts of disease‑linked genes and a possible link between cholesterol regulation and neurodegeneration. The reasoning atlas is publicly available for scientists to explore and prioritize further experiments.
Why it matters
This speeds up the discovery process in brain‑disease research, potentially bringing insights about Alzheimer’s, Parkinson’s and other conditions to researchers much faster. Faster, broader analysis could lead to new treatment ideas earlier than before.
Reality check
An automated, sceptical read of the sourceNotable. The approach scales biological reasoning across thousands of agents, achieving results in minutes that would otherwise take months, showing a clear step beyond incremental AI assistance.
Is this a big deal?
Get stories like this every morning
The day's AI news in plain English, in your inbox at 8:30 IST. Free.
More from OpenAI
Introducing ChatGPT WalletOpenAI · 13 Nov 2026Shield helps technicians hand off legacy portal work with OpenAIOpenAI · 13 Nov 2026OpenAI launches ChatGPT Wallet, AI agents pay for purchaseOpenAI · 13 Nov 2026OpenAI disbands its robotics team as its general models start running robotsOpenAI · 13 Nov 2026Yang-Mills, OpenAI proof, and the mass gap problemOpenAI · 13 Nov 2026This page was collected from openai.com and summarised automatically by AIPulsee's pipeline. See how it runs.